OR

356.05

+1.15%↑

B.US

40.78

+6.34%↑

ASM

666.8

+5.84%↑

IAG.ES

4.22

+3.69%↑

UPM.FI

27

+0.86%↑

OR

356.05

+1.15%↑

B.US

40.78

+6.34%↑

ASM

666.8

+5.84%↑

IAG.ES

4.22

+3.69%↑

UPM.FI

27

+0.86%↑

OR

356.05

+1.15%↑

B.US

40.78

+6.34%↑

ASM

666.8

+5.84%↑

IAG.ES

4.22

+3.69%↑

UPM.FI

27

+0.86%↑

OR

356.05

+1.15%↑

B.US

40.78

+6.34%↑

ASM

666.8

+5.84%↑

IAG.ES

4.22

+3.69%↑

UPM.FI

27

+0.86%↑

OR

356.05

+1.15%↑

B.US

40.78

+6.34%↑

ASM

666.8

+5.84%↑

IAG.ES

4.22

+3.69%↑

UPM.FI

27

+0.86%↑

Search

Interparfums SA.

Open

23.22 0.96

Overview

Share price change

24h

Current

Min

22.8

Max

23.5

Key metrics

By Trading Economics

Income

-20M

53M

Sales

5.5M

452M

P/E

Sector Avg

14.342

32.671

Dividend yield

4.7

Profit margin

11.818

Employees

363

EBITDA

-23M

94M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+32.28% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

4.70%

3.04%

Market Stats

By TradingEconomics

Market Cap

-186M

1.9B

Previous open

22.26

Previous close

23.22

Technical Score

By Trading Central

Confidence

Bullish Evidence

Interparfums SA. Chart

Past performance is not a reliable indicator of future results.

Related News

31 Mar 2026, 23:31 UTC

Hot Stocks

Stocks to Watch: Nike, RH, NCino

31 Mar 2026, 22:35 UTC

Earnings

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 Apr 2026, 00:00 UTC

Acquisitions, Mergers, Takeovers

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 Mar 2026, 23:50 UTC

Acquisitions, Mergers, Takeovers

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 Mar 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 Mar 2026, 23:33 UTC

Market Talk
Major News Events

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 Mar 2026, 23:21 UTC

Earnings

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 Mar 2026, 23:14 UTC

Market Talk
Earnings

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 Mar 2026, 23:12 UTC

Market Talk

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 Mar 2026, 22:36 UTC

Earnings

China Vanke 2025 Loss Widens >000002.SZ

31 Mar 2026, 22:36 UTC

Earnings

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 Mar 2026, 22:36 UTC

Earnings

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 Mar 2026, 22:36 UTC

Earnings

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 Mar 2026, 22:36 UTC

Earnings

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 Mar 2026, 21:46 UTC

Acquisitions, Mergers, Takeovers

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 Mar 2026, 21:36 UTC

Market Talk

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 Mar 2026, 21:35 UTC

Earnings

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 Mar 2026, 21:35 UTC

Earnings

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 Mar 2026, 21:35 UTC

Earnings

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 Mar 2026, 21:33 UTC

Acquisitions, Mergers, Takeovers

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 Mar 2026, 21:33 UTC

Earnings

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 Mar 2026, 21:32 UTC

Earnings

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 Mar 2026, 21:28 UTC

Earnings

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 Mar 2026, 21:26 UTC

Earnings

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 Mar 2026, 21:25 UTC

Earnings

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 Mar 2026, 21:24 UTC

Market Talk
Earnings

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 Mar 2026, 21:22 UTC

Earnings

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 Mar 2026, 21:22 UTC

Earnings

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 Mar 2026, 21:21 UTC

Earnings

Nike's Digital Channel Still Too Promotional, CFO Says

31 Mar 2026, 21:20 UTC

Earnings

Nike CEO: Converse Remains Important to Portfolio

Peer Comparison

Price change

Interparfums SA. Forecast

Price Target

By TipRanks

32.28% upside

12 Months Forecast

Average 30 EUR  32.28%

High 35 EUR

Low 25 EUR

Based on 2 Wall Street analysts offering 12 month price targets forInterparfums SA. - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Technical Score

By Trading Central

35.675 / 36.1Support & Resistance

Short Term

Bullish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Interparfums SA.

Interparfums SA designs, manufactures, and distributes perfumes through license agreements with ready-to-wear, jewelry, or accessories houses in France and internationally. The company operates through Perfumes and Fashion segments. It serves customers under the Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lanvin, Montblanc, Moncler, Rochas, S.T. Dupont, Van Cleef & Arpels, and other brand names. The company distributes its products through wholly owned distribution subsidiaries or joint ventures, independent companies, subsidiaries of luxury good corporations, and duty free operators. Interparfums SA was founded in 1982 and is headquartered in Paris, France. Interparfums SA is a subsidiary of y Interparfums Inc.
help-icon Live chat